Chartered Society of Physiotherapists in UK encourages participants in RAPPER IV MS Trial
People with multiple sclerosis (MS) are being sought to take part in a study that aims to investigate the benefits of a robotic walking device. Read more…
MS Clinical Trials continue in UK
https://multiplesclerosisnewstoday.com/2019/03/07/uk-team-to-test-robotic-exercise-to-improve-balance-in-ms-patients/
MS Clinical Trial starting at East Kent
Rex Bionics is the pioneer of the REX® robotic rehabilitation device that provides standing, walking and exercise support for people with lower limb weakness or paralysis; and is used by people who have suffered a spinal cord injury, stroke, traumatic brain injury or other neurological condition such as multiple sclerosis. Rex Bionics has worked with [...]
REX initiates RAPPER III: Clinical Trial in Multiple Sclerosis
Ethics Committee Approval from NHS’s National Institute for Health Research (NIHR) Partnership with East Kent Hospitals University NHS Foundation Trust, and Kent University Rex Bionics Plc (AIM: RXB), is pleased to announce that the ethics committee of the UK NHS’s National Institute for Health Research has approved the start of a clinical trial to evaluate [...]
REX Stroke and Brain Injury Clinical Trial in Australia
Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, is pleased to announce the start of a new clinical trial treating patients who have had a stroke or brain injury, with Robot-Assisted Physiotherapy with REX. The trial is being conducted by the Australian Institute of [...]